Filtros : "Indexado na Base de dados Embase" "PASSAGLIA, RITA DE CASSIA ALEIXO TOSTES" Removido: "HU" Limpar

Filtros



Refine with date range


  • Source: Cardiovascular Research. Unidade: ICB

    Assunto: FARMACOLOGIA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      YING, Zhekang et al. Salicylates dilate blood vessels through inhibiting PYK2-mediated RhoA/Rho-kinase activation. Cardiovascular Research, v. 83, n. 1, p. 155-162, 2009Tradução . . Disponível em: https://doi.org/10.1093/cvr/cvp084. Acesso em: 31 maio 2024.
    • APA

      Ying, Z., Giachini, F. R. C., Passaglia, R. de C. A. T., & Webb, R. C. (2009). Salicylates dilate blood vessels through inhibiting PYK2-mediated RhoA/Rho-kinase activation. Cardiovascular Research, 83( 1), 155-162. doi:10.1093/cvr/cvp084
    • NLM

      Ying Z, Giachini FRC, Passaglia R de CAT, Webb RC. Salicylates dilate blood vessels through inhibiting PYK2-mediated RhoA/Rho-kinase activation [Internet]. Cardiovascular Research. 2009 ; 83( 1): 155-162.[citado 2024 maio 31 ] Available from: https://doi.org/10.1093/cvr/cvp084
    • Vancouver

      Ying Z, Giachini FRC, Passaglia R de CAT, Webb RC. Salicylates dilate blood vessels through inhibiting PYK2-mediated RhoA/Rho-kinase activation [Internet]. Cardiovascular Research. 2009 ; 83( 1): 155-162.[citado 2024 maio 31 ] Available from: https://doi.org/10.1093/cvr/cvp084
  • Source: Journal of Sexual Medicine. Unidade: ICB

    Assunto: FARMACOLOGIA

    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      CARNEIRO, Fernando Silva et al. TNF-'alfa' knockout mice have increased corpora cavernosa relaxation. Journal of Sexual Medicine, v. 6, n. 1, p. 115-125, 2009Tradução . . Acesso em: 31 maio 2024.
    • APA

      Carneiro, F. S., Sturgis, L. C., Giachini, F. R. C., Carneiro, Z. N., Lima, V. V., Wynne, B. M., et al. (2009). TNF-'alfa' knockout mice have increased corpora cavernosa relaxation. Journal of Sexual Medicine, 6( 1), 115-125.
    • NLM

      Carneiro FS, Sturgis LC, Giachini FRC, Carneiro ZN, Lima VV, Wynne BM, Martin SS, Brands MW, Passaglia R de CAT, Webb RC. TNF-'alfa' knockout mice have increased corpora cavernosa relaxation. Journal of Sexual Medicine. 2009 ; 6( 1): 115-125.[citado 2024 maio 31 ]
    • Vancouver

      Carneiro FS, Sturgis LC, Giachini FRC, Carneiro ZN, Lima VV, Wynne BM, Martin SS, Brands MW, Passaglia R de CAT, Webb RC. TNF-'alfa' knockout mice have increased corpora cavernosa relaxation. Journal of Sexual Medicine. 2009 ; 6( 1): 115-125.[citado 2024 maio 31 ]
  • Source: Expert Opinion on Therapeutic Targets. Unidade: ICB

    Assunto: FARMACOLOGIA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      GIACHINI, Fernanda Regina Casagrande et al. Therapeutic targets in hypertension: is there a place for antagonists of the most potent vasoconstrictors?. Expert Opinion on Therapeutic Targets, v. 12, n. 3, p. 327-339, 2008Tradução . . Disponível em: https://doi.org/10.1517/14728222.12.3.327. Acesso em: 31 maio 2024.
    • APA

      Giachini, F. R. C., Callera, G. E., Carneiro, F. S., Passaglia, R. de C. A. T., & Webb, R. C. (2008). Therapeutic targets in hypertension: is there a place for antagonists of the most potent vasoconstrictors? Expert Opinion on Therapeutic Targets, 12( 3), 327-339. doi:10.1517/14728222.12.3.327
    • NLM

      Giachini FRC, Callera GE, Carneiro FS, Passaglia R de CAT, Webb RC. Therapeutic targets in hypertension: is there a place for antagonists of the most potent vasoconstrictors? [Internet]. Expert Opinion on Therapeutic Targets. 2008 ; 12( 3): 327-339.[citado 2024 maio 31 ] Available from: https://doi.org/10.1517/14728222.12.3.327
    • Vancouver

      Giachini FRC, Callera GE, Carneiro FS, Passaglia R de CAT, Webb RC. Therapeutic targets in hypertension: is there a place for antagonists of the most potent vasoconstrictors? [Internet]. Expert Opinion on Therapeutic Targets. 2008 ; 12( 3): 327-339.[citado 2024 maio 31 ] Available from: https://doi.org/10.1517/14728222.12.3.327
  • Source: Journal of the American Society of the Hypertension. Unidade: ICB

    Assunto: FARMACOLOGIA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      MONTEZANO, Augusto C. et al. Inhibitory effects of PPAR-'gama' on endothelin-1-induced inflammatory pathways in vascular smooth muscle cells from normotensive and hypertensive rats. Journal of the American Society of the Hypertension, v. 1, n. 2, p. 150-160, 2007Tradução . . Disponível em: https://doi.org/10.1016/j.jash.2007.01.005. Acesso em: 31 maio 2024.
    • APA

      Montezano, A. C., Amiri, F., Passaglia, R. de C. A. T., Touyz, R. M., & Schiffrin, E. L. (2007). Inhibitory effects of PPAR-'gama' on endothelin-1-induced inflammatory pathways in vascular smooth muscle cells from normotensive and hypertensive rats. Journal of the American Society of the Hypertension, 1( 2), 150-160. doi:10.1016/j.jash.2007.01.005
    • NLM

      Montezano AC, Amiri F, Passaglia R de CAT, Touyz RM, Schiffrin EL. Inhibitory effects of PPAR-'gama' on endothelin-1-induced inflammatory pathways in vascular smooth muscle cells from normotensive and hypertensive rats [Internet]. Journal of the American Society of the Hypertension. 2007 ; 1( 2): 150-160.[citado 2024 maio 31 ] Available from: https://doi.org/10.1016/j.jash.2007.01.005
    • Vancouver

      Montezano AC, Amiri F, Passaglia R de CAT, Touyz RM, Schiffrin EL. Inhibitory effects of PPAR-'gama' on endothelin-1-induced inflammatory pathways in vascular smooth muscle cells from normotensive and hypertensive rats [Internet]. Journal of the American Society of the Hypertension. 2007 ; 1( 2): 150-160.[citado 2024 maio 31 ] Available from: https://doi.org/10.1016/j.jash.2007.01.005
  • Source: Recent Patents on Cardiovascular Drug Discovery. Unidade: ICB

    Assunto: FARMACOLOGIA

    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      LEITE, Romulo et al. Targets for the treatment of erectile dysfunction: is NO/cGMP still the answer?. Recent Patents on Cardiovascular Drug Discovery, v. 2, n. 2, p. 119-132, 2007Tradução . . Acesso em: 31 maio 2024.
    • APA

      Leite, R., Giachini, F. R. C., Carneiro, F. S., Nunes, K. P., Passaglia, R. de C. A. T., & Webb, R. C. (2007). Targets for the treatment of erectile dysfunction: is NO/cGMP still the answer? Recent Patents on Cardiovascular Drug Discovery, 2( 2), 119-132.
    • NLM

      Leite R, Giachini FRC, Carneiro FS, Nunes KP, Passaglia R de CAT, Webb RC. Targets for the treatment of erectile dysfunction: is NO/cGMP still the answer? Recent Patents on Cardiovascular Drug Discovery. 2007 ; 2( 2): 119-132.[citado 2024 maio 31 ]
    • Vancouver

      Leite R, Giachini FRC, Carneiro FS, Nunes KP, Passaglia R de CAT, Webb RC. Targets for the treatment of erectile dysfunction: is NO/cGMP still the answer? Recent Patents on Cardiovascular Drug Discovery. 2007 ; 2( 2): 119-132.[citado 2024 maio 31 ]
  • Source: Expert Review of Cardiovascular Therapy. Unidade: ICB

    Assunto: FARMACOLOGIA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      CALLERA, Glaucia et al. Vasoactive peptides in cardiovascular (patho)physiology. Expert Review of Cardiovascular Therapy, v. 5, n. 3, p. 531-552, 2007Tradução . . Disponível em: https://doi.org/10.1586/14779072.5.3.531. Acesso em: 31 maio 2024.
    • APA

      Callera, G., Passaglia, R. de C. A. T., Savoia, C., Muscará, M. N., & Touyz, R. M. (2007). Vasoactive peptides in cardiovascular (patho)physiology. Expert Review of Cardiovascular Therapy, 5( 3), 531-552. doi:10.1586/14779072.5.3.531
    • NLM

      Callera G, Passaglia R de CAT, Savoia C, Muscará MN, Touyz RM. Vasoactive peptides in cardiovascular (patho)physiology [Internet]. Expert Review of Cardiovascular Therapy. 2007 ; 5( 3): 531-552.[citado 2024 maio 31 ] Available from: https://doi.org/10.1586/14779072.5.3.531
    • Vancouver

      Callera G, Passaglia R de CAT, Savoia C, Muscará MN, Touyz RM. Vasoactive peptides in cardiovascular (patho)physiology [Internet]. Expert Review of Cardiovascular Therapy. 2007 ; 5( 3): 531-552.[citado 2024 maio 31 ] Available from: https://doi.org/10.1586/14779072.5.3.531
  • Source: Hypertension. Unidade: ICB

    Assunto: FARMACOLOGIA

    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      CERAVOLO, Graziela S. et al. Angiotensin II chronic infusion induces B1 receptor expression in aorta of rats. Hypertension, v. 50, n. 4, p. 756-761, 2007Tradução . . Acesso em: 31 maio 2024.
    • APA

      Ceravolo, G. S., Fernandes, L., Munhoz, C. D., Fernandes, D. C., Passaglia, R. de C. A. T., Laurindo, F. R. M., et al. (2007). Angiotensin II chronic infusion induces B1 receptor expression in aorta of rats. Hypertension, 50( 4), 756-761.
    • NLM

      Ceravolo GS, Fernandes L, Munhoz CD, Fernandes DC, Passaglia R de CAT, Laurindo FRM, Scavone C, Fortes ZB, Carvalho MHC de. Angiotensin II chronic infusion induces B1 receptor expression in aorta of rats. Hypertension. 2007 ; 50( 4): 756-761.[citado 2024 maio 31 ]
    • Vancouver

      Ceravolo GS, Fernandes L, Munhoz CD, Fernandes DC, Passaglia R de CAT, Laurindo FRM, Scavone C, Fortes ZB, Carvalho MHC de. Angiotensin II chronic infusion induces B1 receptor expression in aorta of rats. Hypertension. 2007 ; 50( 4): 756-761.[citado 2024 maio 31 ]

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024